SB271
Prescription Drug Affordability Board; established, drug cost affordability review, report.
Status:
In House
Latest Action:
Feb. 10, 2026
Senate: Fiscal Impact Statement from Department of Planning and Budget (SB271)
Chief Patron:
Creigh Deeds (D)
Session:
2026 Regular Session
Summary
As Introduced. Prescription Drug Affordability Board established; drug cost affordability review.
Establishes the Prescription Drug Affordability Board (the Board) for the purpose of protecting the citizens of the Commonwealth and other stakeholders within the health care system from the high costs of prescription drug products. The bill requires the Board to meet in open session at least four times annually, with ... (More) certain exceptions and requirements enumerated in the bill. Members of the Board are required to disclose any conflicts of interest, as described in the bill. The bill also creates a stakeholder council for the purpose of assisting the Board in making decisions related to drug cost affordability. The bill tasks the Board with conducting affordability reviews of certain prescription drugs that are offered for sale in the Commonwealth. The bill lists factors for the Board to consider that indicate an affordability challenge for the health care system in the Commonwealth or high out-of-pocket costs for patients. The bill also provides that any person aggrieved by a decision of the Board may request an appeal of the Board's decision and that the Attorney General has authority to enforce the provisions of the bill. (Less)-
Bill History
- 01/12/2026 - Senate: Prefiled and ordered printed; Offered 01-14-2026 26105318D
- 01/12/2026 - Senate: Referred to Committee on Education and Health
- 01/22/2026 - Senate: Rereferred from Education and Health to Commerce and Labor (14-Y 0-N)
- 01/22/2026 - Senate: Rereferred to Commerce and Labor
- 01/26/2026 - Senate: Senate committee offered
- 01/26/2026 - Senate: Reported from Commerce and Labor with amendments and rereferred to Finance and Appropriations (10-Y 4-N 1-A)
- 01/26/2026 - Senate: Rereferred to Finance and Appropriations
- 01/27/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB271)
- 02/03/2026 - Senate: Reported from Finance and Appropriations (9-Y 5-N 1-A)
- 02/04/2026 - Senate: Rules suspended
- 02/04/2026 - Senate: Constitutional reading dispensed Block Vote (on 1st reading) (40-Y 0-N 0-A)
- 02/04/2026 - Senate: Passed by for the day Block Vote (Voice Vote)
- 02/05/2026 - Senate: Read second time
- 02/05/2026 - Senate: Commerce and Labor Amendments agreed to
- 02/05/2026 - Senate: Engrossed by Senate as amended (Voice Vote)
- 02/06/2026 - Senate: Read third time and passed Senate (31-Y 8-N 0-A)
- 02/10/2026 - Senate: Fiscal Impact Statement from Department of Planning and Budget (SB271)
